New Hope for Stomach Cancer: Combining Immunotherapy and Chemotherapy Before Surgery

Aug 14, 2025

Can starting immunotherapy before surgery change the future of stomach and esophageal cancer treatment? A 2024 study called the PANDA trial, published in Nature Medicine, tested this very idea—and the early results are promising. Researchers found that combining immunotherapy with chemotherapy before surgery may dramatically improve tumor response and long-term outcomes.

Reported by

Reviewed by

You May Also Like